Key Details
Price
$0.97Annual ROE
-34.10%Beta
0.53Events Calendar
Next earnings date:
Mar 20, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Mar 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 13, 25 HC Wainwright & Co.
BuyNov 19, 24 HC Wainwright & Co.
BuyNov 8, 24 HC Wainwright & Co.
BuyOct 1, 24 HC Wainwright & Co.
BuySep 26, 24 HC Wainwright & Co.
BuyAug 13, 24 Alliance Global Partners
BuyAug 12, 24 HC Wainwright & Co.
BuyJun 13, 24 Barclays
OverweightJun 7, 24 HC Wainwright & Co.
BuyMay 16, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Barinthus Biotherapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Barinthus Biotherapeutics?
- Does Barinthus Biotherapeutics pay dividends?
- What sector is Barinthus Biotherapeutics in?
- What industry is Barinthus Biotherapeutics in?
- What country is Barinthus Biotherapeutics based in?
- When did Barinthus Biotherapeutics go public?
- Is Barinthus Biotherapeutics in the S&P 500?
- Is Barinthus Biotherapeutics in the NASDAQ 100?
- Is Barinthus Biotherapeutics in the Dow Jones?
- When was Barinthus Biotherapeutics's last earnings report?
- When does Barinthus Biotherapeutics report earnings?
- Should I buy Barinthus Biotherapeutics stock now?
What is the ticker symbol for Barinthus Biotherapeutics?
The ticker symbol for Barinthus Biotherapeutics is NASDAQ:BRNS
Does Barinthus Biotherapeutics pay dividends?
No, Barinthus Biotherapeutics does not pay dividends
What sector is Barinthus Biotherapeutics in?
Barinthus Biotherapeutics is in the Healthcare sector
What industry is Barinthus Biotherapeutics in?
Barinthus Biotherapeutics is in the Biotechnology industry
What country is Barinthus Biotherapeutics based in?
Barinthus Biotherapeutics is headquartered in United Kingdom
When did Barinthus Biotherapeutics go public?
Barinthus Biotherapeutics's initial public offering (IPO) was on April 30, 2021
Is Barinthus Biotherapeutics in the S&P 500?
No, Barinthus Biotherapeutics is not included in the S&P 500 index
Is Barinthus Biotherapeutics in the NASDAQ 100?
No, Barinthus Biotherapeutics is not included in the NASDAQ 100 index
Is Barinthus Biotherapeutics in the Dow Jones?
No, Barinthus Biotherapeutics is not included in the Dow Jones index
When was Barinthus Biotherapeutics's last earnings report?
Barinthus Biotherapeutics's most recent earnings report was on Nov 6, 2024
When does Barinthus Biotherapeutics report earnings?
The next expected earnings date for Barinthus Biotherapeutics is Mar 20, 2025
Should I buy Barinthus Biotherapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions